DAG Ventures v-Qp, L.P. Sample Contracts

AGREEMENT
Agreement • February 13th, 2018 • DAG Ventures v-Qp, L.P. • Biological products, (no disgnostic substances)

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of AtaraBiotherapeutics, Inc.

Sample 1
AutoNDA by SimpleDocs
AGREEMENT
Agreement • February 17th, 2015 • DAG Ventures v-Qp, L.P. • Biological products, (no disgnostic substances)

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Atara Biotherapeutics, Inc.

Sample 1
AGREEMENT
Agreement • February 7th, 2019 • DAG Ventures v-Qp, L.P. • Biological products, (no disgnostic substances)

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Atara Biotherapeutics, Inc.

Sample 1
AGREEMENT
Agreement • February 10th, 2016 • DAG Ventures v-Qp, L.P. • Biological products, (no disgnostic substances)

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Atara Biotherapeutics, Inc.

Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.